Activation of the liver X receptor increases neuroactive steroid levels and protects from diabetes-induced peripheral neuropathy
- PMID: 20826654
- PMCID: PMC3049178
- DOI: 10.1523/JNEUROSCI.1898-10.2010
Activation of the liver X receptor increases neuroactive steroid levels and protects from diabetes-induced peripheral neuropathy
Abstract
Neuroactive steroids act in the peripheral nervous system as physiological regulators and as protective agents for acquired or inherited peripheral neuropathy. In recent years, modulation of neuroactive steroids levels has been studied as a potential therapeutic approach to protect peripheral nerves from damage induced by diabetes. Nuclear receptors of the liver X receptor (LXR) family regulate adrenal steroidogenesis via their ability to control cholesterol homeostasis. Here we show that rat sciatic nerve expresses both LRXα and β isoforms and that these receptors are functional. Activation of liver X receptors using a synthetic ligand results in increased levels of neurosteroids and protection of the sciatic nerve from neuropathy induced by diabetes. LXR ligand treatment of streptozotocin-treated rats increases expression in the sciatic nerve of steroidogenic acute regulatory protein (a molecule involved in the transfer of cholesterol into mitochondria), of the enzyme P450scc (responsible for conversion of cholesterol into pregnenolone), of 5α-reductase (an enzyme involved in the generation of neuroactive steroids) and of classical LXR targets involved in cholesterol efflux, such as ABCA1 and ABCG1. These effects were associated with increased levels of neuroactive steroids (e.g., pregnenolone, progesterone, dihydroprogesterone and 3α-diol) in the sciatic nerve, and with neuroprotective effects on thermal nociceptive activity, nerve conduction velocity, and Na(+), K(+)-ATPase activity. These results suggest that LXR activation may represent a new pharmacological avenue to increase local neuroactive steroid levels that exert neuroprotective effects in diabetic neuropathy.
Figures





Similar articles
-
Progesterone and its derivatives are neuroprotective agents in experimental diabetic neuropathy: a multimodal analysis.Neuroscience. 2007 Feb 23;144(4):1293-304. doi: 10.1016/j.neuroscience.2006.11.014. Epub 2006 Dec 20. Neuroscience. 2007. PMID: 17187935
-
Neuroprotective effects of a ligand of translocator protein-18 kDa (Ro5-4864) in experimental diabetic neuropathy.Neuroscience. 2009 Dec 1;164(2):520-9. doi: 10.1016/j.neuroscience.2009.08.005. Epub 2009 Aug 7. Neuroscience. 2009. PMID: 19665520
-
Neuroactive steroid treatment modulates myelin lipid profile in diabetic peripheral neuropathy.J Steroid Biochem Mol Biol. 2014 Sep;143:115-21. doi: 10.1016/j.jsbmb.2014.02.015. Epub 2014 Mar 4. J Steroid Biochem Mol Biol. 2014. PMID: 24607810
-
Neuroactive steroids and peripheral myelin proteins.Brain Res Brain Res Rev. 2001 Nov;37(1-3):360-71. doi: 10.1016/s0165-0173(01)00140-0. Brain Res Brain Res Rev. 2001. PMID: 11744100 Review.
-
Levels and actions of progesterone and its metabolites in the nervous system during physiological and pathological conditions.Prog Neurobiol. 2014 Feb;113:56-69. doi: 10.1016/j.pneurobio.2013.07.006. Epub 2013 Aug 16. Prog Neurobiol. 2014. PMID: 23958466 Review.
Cited by
-
Supportive care of female hormones in brain health: what and how?Front Pharmacol. 2024 Jul 24;15:1403969. doi: 10.3389/fphar.2024.1403969. eCollection 2024. Front Pharmacol. 2024. PMID: 39114348 Free PMC article. Review.
-
Role of neuroactive steroids in the peripheral nervous system.Front Endocrinol (Lausanne). 2011 Dec 27;2:104. doi: 10.3389/fendo.2011.00104. eCollection 2011. Front Endocrinol (Lausanne). 2011. PMID: 22654839 Free PMC article.
-
LXR agonist improves peripheral neuropathy and modifies PNS immune cells in aged mice.J Neuroinflammation. 2022 Feb 26;19(1):57. doi: 10.1186/s12974-022-02423-z. J Neuroinflammation. 2022. PMID: 35219337 Free PMC article.
-
Cholesterol-dependent LXR transcription factor activity represses pronociceptive effects of estrogen in sensory neurons and pain induced by myelin basic protein fragments.Brain Behav Immun Health. 2024 Mar 30;38:100757. doi: 10.1016/j.bbih.2024.100757. eCollection 2024 Jul. Brain Behav Immun Health. 2024. PMID: 38590761 Free PMC article.
-
Diabetes-induced myelin abnormalities are associated with an altered lipid pattern: protective effects of LXR activation.J Lipid Res. 2012 Feb;53(2):300-10. doi: 10.1194/jlr.M021188. Epub 2011 Dec 7. J Lipid Res. 2012. PMID: 22158827 Free PMC article.
References
-
- American Diabetes Association [ADA] Standards of medical care in diabetes—2007. Diabetes Care. 2007;30(Suppl 1):S4–S41. - PubMed
-
- Beaven SW, Tontonoz P. Nuclear receptors in lipid metabolism: targeting the heart of dyslipidemia. Annu Rev Med. 2006;57:313–329. - PubMed
-
- Bianchi R, Buyukakilli B, Brines M, Savino C, Cavaletti G, Oggioni N, Lauria G, Borgna M, Lombardi R, Cimen B, Comelekoglu U, Kanik A, Tataroglu C, Cerami A, Ghezzi P. Erythropoietin both protects from and reverses experimental diabetic neuropathy. Proc Natl Acad Sci U S A. 2004;101:823–828. - PMC - PubMed
-
- Bogan RL, Davis TL, Niswender GD. Peripheral-type benzodiazepine receptor (PBR) aggregation and absence of steroidogenic acute regulatory protein (StAR)/PBR association in the mitochondrial membrane as determined by bioluminescence resonance energy transfer (BRET) J Steroid Biochem Mol Biol. 2007;104:61–67. - PubMed
-
- Caruso D, Scurati S, Maschi O, De Angelis L, Roglio I, Giatti S, Garcia-Segura LM, Melcangi RC. Evaluation of neuroactive steroid levels by liquid chromatography-tandem mass spectrometry in central and peripheral nervous system: effect of diabetes. Neurochem Int. 2008;52:560–568. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical